Picture [iito] Made Without Love 650x80px

News > All

Total search results: 6994 | Ordered by Date (descending)
1 2 3 ... 68 69 70  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Patient Square Capital L.P.. (3/16/23). "Press Release: Patient Square Capital Partners with Health Care Veteran John Marotta to Focus on Life Science Tools and Diagnostics Opportunities". Menlo Park, CA. 2023-03-16
Aldena Therapeutics Inc.. (3/16/23). "Press Release: Aldena Therapeutics Accelerates Its Novel and Disruptive Approach to Immuno-Dermatology". Boston, MA. 2023-03-16
Seamless Therapeutics GmbH. (3/16/23). "Press Release: Seamless Therapeutics Launches with $12.5M Seed Financing to Advance Transformative Gene Editing Platform Based on Programmable Precision Designer Recombinases". Dresden. 2023-03-16
UCB S.A.. (3/15/23). "Press Release: Aitia and UCB Announce Strategic Drug Discovery Collaboration in Huntington's Disease". Brussels & Somerville, MA. 2023-03-15
Mediar Therapeutics Inc.. (3/15/23). "Press Release: Mediar Therapeutics Announces $105 Million Financing to Advance Portfolio of First-in-Class Fibrosis Therapies". Cambridge, MA. 2023-03-15
Owlstone Medical Ltd.. (3/15/23). "Press Release: Owlstone Medical Enters Partnership with Bicycle Therapeutics for the Development of Antigen-Targeted EVOC Probes for Early Cancer Detection". Cambridge. 2023-03-15
Exscientia plc. (3/14/23). "Press Release: Exscientia Announces Expansion of its Precision Oncology Pipeline". Oxford. 2023-03-14
CN Bio Innovations Ltd.. (3/14/23). "Press Release: CN Bio Appoints Deepak Singh as Vice President of Sales and Marketing". Cambridge. 2023-03-14
Bayer AG. (3/14/23). "Press Release: BlueRock Therapeutics to Incorporate Wearable and Invisible Contactless Digital Health Technologies from Rune Labs and Emerald Innovations in Parkinson’s Disease Clinical Trial". Cambridge. 2023-03-14
Bayer AG. (3/14/23). "Press Release: Bayer Collaborates with Microsoft to Unveil New Cloud-based Enterprise Solutions, advancing innovation and transparency in the agri-food industry". San Francisco, CA. 2023-03-14
Sanofi S.A.. (3/13/23). "Press Release: Sanofi to Acquire Provention Bio, Adding to Portfolio TZIELD, the First Disease-modifying Treatment for the Delay of Stage 3 Type 1 Diabetes (T1D)". Paris & Red Bank, NJ. 2023-03-13
Seagen Inc.. (3/13/23). "Press Release: Pfizer Invests $43 Billion to Battle Cancer. Pfizer to Acquire Seagen for $229 per Seagen Share in Cash". New York, NY & Bothell, WA. 2023-03-13
Iktos S.A.S.. (3/9/23). "Press Release: Iktos Raises € 15.5m Series A Round to Expand Its Artificial Intelligence-based Drug Discovery Technologies and Solutions". Paris & Lausanne. 2023-03-09
Bayer AG. (3/9/23). "Press Release: AskBio Announces Gustavo Pesquin as New CEO". Research Triangle Park, NC. 2023-03-09
UCB S.A.. (3/9/23). "Press Release: UCB’s Board of Directors Appoints Jonathan Peacock as New Chair". Brussels. 2023-03-09
Exscientia plc. (3/7/23). "Press Release: Exscientia Announces Collaboration with Charité to Advance Development of Precision Medicine Platform". Oxford & Berlin. 2023-03-07
Personalis, Inc.. (3/7/23). "Press Release: Personalis Selected for Clinical Research After Successful Evaluation of Whole Genome-Based Molecular Residual Disease Assay". Fremont, CA. 2023-03-07
Noema Pharma AG. (3/7/23). "Press Release: Noema Pharma Raises CHF 103 million (USD 112 million) in Series B Financing Round Led by Forbion and Jeito Capital". Basel. 2023-03-07
Cellbox Solutions GmbH. (3/7/23). "Press Release: Cellbox Solutions Raises EUR 6.5 Million in Series A1 Financing Round". Norderstedt. 2023-03-07
Eppendorf SE. (3/6/23). "Press Release: Eppendorf Divests Micro Manipulation Product Portfolio". Hamburg. 2023-03-06
Oculis Holding AG. (3/3/23). "Press Release: Oculis Announces US Public Listing on NASDAQ". Lausanne & Zug. 2023-03-03
Confo Therapeutics N.V.. (3/2/23). "Press Release: Confo Therapeutics Announces Global Licensing Agreement with Lilly for Peripheral Pain Candidate, CFTX-1554". Ghent. 2023-03-02
SHS Gesellschaft für Beteiligungsmanagement mbH. (3/2/23). "Press Release: More Patient Safety with Simulators for Cardiologists – SHS Invests 10 Million Euro in Swiss Simulands AG". Tübingen. 2023-03-02
Personalis, Inc.. (3/2/23). "Press Release: Personalis Appoints Christopher Hall as Chief Executive Officer". Fremont, CA. 2023-03-02
Tempus Labs, Inc.. (2/28/23). "Press Release: Tempus Announces New Strategic Collaboration with Pfizer to Advance Oncology Therapeutic Development". 2023-02-28
Bico Group AB. (2/27/23). "Press Release: Bico Introduces New Life Sciences Manufacturing Platform Integrating ABB Robotics Technology". 2023-02-27
CRISPR Therapeutics AG. (2/27/23). "Press Release: CRISPR Therapeutics to Participate in the 43rd Annual Cowen Health Care Conference". Zug & Boston, MA. 2023-02-27
ObsEva S.A.. (2/24/23). "Press Release: ObsEva Announces Strategic Reorganization to Consolidate Operations in Switzerland". Geneva. 2023-02-24
Tempus Labs, Inc.. (2/23/23). "Press Release: Tempus Announces New Multi-omics Collaboration with Actuate Therapeutics". 2023-02-23
Cerevance. (2/23/23). "Press Release: Cerevance Expands Series B Financing with Additional $51 Million". Boston, MA. 2023-02-23
Monod Bio Inc.. (2/22/23). "Press Release: Monod Bio Announces Publication in Nature Highlighting De Novo Protein Technology Platform for the Creation of Novel Luciferases". Seattle, WA. 2023-02-22
CRISPR Therapeutics AG. (2/21/23). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results". Zug & Boston, MA. 2023-02-21
Hemab ApS. (2/21/23). "Press Release: Hemab Therapeutics Announces $135M Series B Financing to Advance First Prophylactic Treatments for Underserved Bleeding and Thrombotic Disorders". Copenhagen & Boston, MA. 2023-02-21
Consilium Strategic Communications Ltd.. (2/20/23). "Press Release: Consilium Strategic Communications Expands International Presence in US and Europe with Two Senior Strategic Advisor Appointments". London. 2023-02-20
Targovax ASA. (2/16/23). "Press Release: Targovax Announces Financing of up to NOK 300m Over Three Years to Advance Its Clinical Cancer Programs and Pre-clinical Circular RNA platform". Oslo. 2023-02-16
Panekès Partners SGR S.p.A.. (2/16/23). "Press Release: Panakès Partners Announces the Final Closing of the »Purple« Fund at 175 Million Euros". Milan. 2023-02-16
Andera Partners. (2/16/23). "Press Release: Ahead of Its Business Plan, Andera Partners Approaches 4 Billion Euros in Assets Under Management and Announces a New 2028 Target of 6 to 8 Billion Euros". Paris. 2023-02-16
Avilar Therapeutics, Inc.. (2/16/23). "Press Release: Avilar Therapeutics Increases Financing to $75 Million to Advance Pipeline of Novel Extracellular Protein Degraders". Waltham, MA. 2023-02-16
Biotage AB. (2/15/23). "Press Release: Biotage Strengthens Its Position as a Global Chromatography Leader with the Transformative Acquisition of Astrea Bioseparations". Uppsala. 2023-02-15
Waters Corporation. (2/15/23). "Press Release: Waters Corporation to Acquire Wyatt Technology, Light Scattering Instrument and Software Leader". Milford, MA. 2023-02-15
Charles River Laboratories International, Inc.. (2/15/23). "Press Release: Charles River and Purespring Therapeutics Announce Gene Therapy Manufacturing Collaboration". Wilmington, MA. 2023-02-15
Maxion Therapeutics Ltd.. (2/15/23). "Press Release: Maxion Therapeutics’ $16 Million Series A to Drive Antibody Development for Previously Untreatable Ion Channel and GPCR-driven Diseases". Cambridge. 2023-02-15
Epigenomics AG. (2/15/23). "Press Release: Epigenomics Decides to Restructure to Minimize Costs". Berlin & San Diego, CA. 2023-02-15
Replay Holdings LLC. (2/14/23). "Press Release: KKR-backed Replay and MD Anderson Form New Product Company Syena to Pioneer First-in-class TCR-NK Cell Therapy". San Diego, CA, London & Houston, TX. 2023-02-14
Disc Medicine, Inc.. (2/14/23). "Press Release: Disc Medicine Announces $62.5 Million Financing Led by Bain Capital Life Sciences to Advance Portfolio of Novel Hematology Programs". Watertown, MA. 2023-02-14
Bayer AG. (2/13/23). "Press Release: Bayer Completes Acquisition of Blackford Analysis Ltd. [not intended for U.S. and UK Media]". Berlin. 2023-02-13
Cydar Ltd.. (2/13/23). "Press Release: Cydar Medical Raises $11.5M (£9.3M) in Series A Funding Round". Cambridge. 2023-02-13
Hookipa Pharma Inc.. (2/13/23). "Press Release: Hookipa Achieves $10 Million Milestone Payment in Development of Immunotherapy for KRAS-Mutated Cancers". New York, NY & Vienna. 2023-02-13
Hexagon Bio, Inc.. (2/13/23). "Press Release: Hexagon Bio Raises $77.3 Million Series B Financing and Strengthens Leadership to Expand Novel Computational Discovery Platform and Advance Microbial Genome-Derived Small Molecules". Menlo Park, CA. 2023-02-13
BioNTech SE. (2/10/23). "Press Release: Pfizer and BioNTech Initiate Phase 1/2 Study of First mRNA-based Shingles Vaccine Program". New York, NY & Mainz. 2023-02-10
Mineralys Therapeutics, Inc.. (2/9/23). "Press Release: Mineralys Therapeutics Announces Pricing of Upsized Initial Public Offering". Radnor, PA. 2023-02-09
Bayer AG. (2/8/23). "Press Release: Bill Anderson to Become CEO of Bayer AG". Leverkusen. 2023-02-08
Icosagen AS. (2/8/23). "Press Release: InvestEU – EIB Agrees to a €18 Million Loan to Estonian Biotech Icosagen for Innovative R&D Technologies and New cGMP Production Facility". Tartu. 2023-02-08
CureVac N.V.. (2/8/23). "Press Release: CureVac Announces Pricing of Upsized Public Offering of Common Shares". Tübingen & Boston, MA. 2023-02-08
TVM Capital Life Science. (2/8/23). "Press Release: TVM Capital Life Science Announces Creation of LAmAb Biologics to Develop Innovative Preventative Therapy for Allergy Patients". Montréal, QC & Munich. 2023-02-08
Spexis AG. (2/8/23). "Press Release: Spexis and SPRIM Global Investments (SGI) Announce Plans for Clinical Trial Partnership to Fund up to Half of the Projected Phase 3 Clinical Development Costs of ColiFin (Ad hoc annuncement)". Allschwil. 2023-02-08
Evonetix Ltd.. (2/7/23). "Press Release: Evonetix Closes $24 Million USD (£20 Million) Financing. Oversubscribed Round Led by Foresite Capital". Cambridge. 2023-02-07
Evotec SE. (2/7/23). "Press Release: Laetitia Rouxel to Succeed Enno Spillner as Chief Financial Officer". Hamburg. 2023-02-07
Qiagen N.V.. (2/7/23). "Press Release: Qiagen Exceeds Outlook for Fourth Quarter and Full-year 2022 with 14% CER Sales Growth in FY 2022 from Non-COVID Product Groups". Venlo. 2023-02-07
CureVac N.V.. (2/6/23). "Press Release: CureVac Announces Proposed Public Offering of Common Shares". Tübingen & Boston, MA. 2023-02-06
Cellvie Inc.. (2/6/23). "Press Release: Cellvie Closes $5.5M of Additional Funding to Accelerate the Development of Therapeutic Mitochondria Transplantation". Tübingen & Boston, MA. 2023-02-06
Structure Therapeutics Inc.. (2/2/23). "Press Release: Structure Therapeutics Announces Pricing of Upsized Initial Public Offering". San José, CA & Shanghai. 2023-02-02
BioNTech SE. (2/2/23). "Press Release: BioNTech Strengthens Manufacturing Capabilities with First In-House Plasmid DNA Manufacturing Facility". Mainz. 2023-02-02
Patient Square Capital L.P.. (2/1/23). "Press Release: Patient Square Capital Announces Record $3.9 Billion Inaugural Fund". Menlo Park, CA. 2023-02-01
Exothera S.A.. (2/1/23). "Press Release: Exothera Announces the Appointment of Darren Leva as Chief Business Officer". Jumet. 2023-02-01
Uniqure N.V.. (1/31/23). "Press Release: uniQure and Apic Bio Enter into Global Licensing Agreement for APB-102, a Clinical Stage Gene Therapy for Patients with ALS Caused by Mutations in SOD1". Lexington, MA, Amsterdam & Cambridge, MA. 2023-01-31
Toulouse White Biotech (TWB). (1/31/23). "Press Release: TWB Announces a Strategic Partnership with Canadian Multinational Premier Tech". Toulouse. 2023-01-31
Charles River Laboratories International, Inc.. (1/30/23). "Press Release: Charles River Laboratories Acquires SAMDI Tech". Wilmington, MA. 2023-01-30
Jasper Therapeutics, Inc.. (1/27/23). "Press Release: Jasper Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares". Redwood City, CA. 2023-01-27
Endress+Hauser AG. (1/27/23). "Press Release: Change at the Top of Analytik Jena. Ulrich Krauss Charts New Course; Oliver Klaeffling Set to Become Managing Director". 2023-01-27
Profluent Bio Inc.. (1/26/23). "Press Release: Profluent Launches to Design New Proteins with Generative AI". Berkeley, CA. 2023-01-26
Evotec SE. (1/26/23). "Press Release: Evotec Announces Agreement with Janssen to Develop Immune-based Therapies". Hamburg. 2023-01-26
Co.don GmbH. (1/25/23). "Press Release: Co.don Finally Saved – Investor Has Taken Over the Business Operations of the Leipzig-based Biopharmacy Vompany with an Additional Location in Teltow, Brandenburg". Leipzig & Teltow. 2023-01-25
Indivumed GmbH. (1/25/23). "Press Release: Crown Bioscience to Acquire Indivumed’s Service Business and Supporting Biobank". San Diego, CA & Hamburg. 2023-01-25
Paradigm Health, Inc.. (1/25/23). "Press Release: Paradigm Launches with $203 Million to Rebuild the Clinical Research Ecosystem". New York, NY. 2023-01-25
Memo Therapeutics AG. (1/24/23). "Press Release: Memo Therapeutics AG Announces Positive Phase I Data with AntiBKV for Treatment of BKV Infection in Renal Transplant Patients". Schlieren. 2023-01-24
Novartis AG. (1/24/23). "Press Release: Sandoz Announces Agreement to Acquire Leading Antifungal Agent Mycamine from Astellas, Reinforcing Hospital Offering and Leading Anti-infectives Portfolio". Basel. 2023-01-24
AI Medical Technology. (1/24/23). "Press Release: AI Medical Technology Nets SEK10.8 Million to Accelerate Dermalyser AI-driven Diagnostic Support Tool for Skin Cancer". Stockholm. 2023-01-24
Qiagen N.V.. (1/23/23). "Press Release: Qiagen Digital Insights Launches Ultra-fast NGS Analysis Able to Process a Whole Genome in 25 Minutes for a $1 in Cloud Computing Costs". Redwood City, CA & Hilden. 2023-01-23
TME Pharma N.V.. (1/23/23). "Press Release: TME Pharma Provides Clinical Update on the GLORIA Expansion Arm Testing NOX-A12 in Combination with Radiotherapy and Bevacizumab in Patients with Glioblastoma". Berlin. 2023-01-23
DeuterOncology N.V.. (1/19/23). "Press Release: DeuterOncology Closes €5.65M Series A Financing Round". Liège. 2023-01-19
Bayer AG. (1/19/23). "Press Release: Bayer Launches New Collaboration with Oerth Bio to Further Advance Innovations in Crop Protection". Monheim & Durham NC. 2023-01-19
Bayer AG. (1/18/23). "Press Release: Bayer Acquires Blackford Analysis Ltd. Bolstering the company’s Position in Digital Medical Imaging [not intended for U.S. and UK Media]". Berlin. 2023-01-18
Proscia Inc.. (1/18/23). "Press Release: Netherlands Cancer Institute (NKI) Selects Proscia To Drive Personalized Diagnosis". Amsterdam & Philadelphia, PA. 2023-01-18
Medigene AG. (1/18/23). "Press Release: Medigene Receives $3 Million Milestone Payment from 2seventy bio". Planegg. 2023-01-18
Plasmion GmbH. (1/18/23). "Press Release: Plasmion and Agilent Technologies Announce Co-marketing Agreement to Provide Solutions for Life Sciences and Applied Chemical Markets". Augsburg. 2023-01-18
Optibrium Ltd.. (1/17/23). "Press Release: Optibrium Appoints Steve Yemm as Chief Commercial Officer". Cambridge. 2023-01-17
BioGeneration Ventures B.V.. (1/17/23). "Press Release: BGV Appoints Jaap de Bruin as FIRST Fund Investment Manager and Promotes Rianne Ellenbroek to Principal". Amsterdam. 2023-01-17
Leap Therapeutics, Inc.. (1/17/23). "Press Release: Leap Therapeutics Acquires Flame Biosciences". Cambridge, MA. 2023-01-17
Pureos Partners AG. (1/17/23). "Press Release: Pureos Partners Welcomes Dr. Ulf Grawunder to Its Team as Venture Partner". Pfäffikon. 2023-01-17
InDevR, Inc.. (1/17/23). "Press Release: InDevR Raises $9 Million in Series B Financing and Partners with bioMérieux". Boulder, CO. 2023-01-17
Qiagen N.V.. (1/17/23). "Press Release: Qiagen Launches EZ2 Connect MDx Platform for Automated Sample Processing in". Venlo. 2023-01-17
AstraZeneca plc. (1/16/23). "Press Release: Acquisition of Neogene Therapeutics Completed". 2023-01-16
TetraScience, Inc.. (1/12/23). "Press Release: Labforward Joins the Tetra Partner Network to Eliminate Data Silos and Error-Prone Data Transfers". Boston, MA. 2023-01-12
Bayer AG. (1/11/23). "Press Release: Bayer to Accelerate Drug Discovery with Google Cloud’s High-Performance Compute Power". Berlin & Sunnyvale, CA. 2023-01-11
Sanofi S.A.. (1/11/23). "Press Release: Sanofi Ventures Announces Multi-year Capital Commitment from Sanofi, Increasing Evergreen Fund to $750M". Paris. 2023-01-11
TATAA Biocenter AB. (1/11/23). "Press Release: TATAA Biocenter Partners with Universal Sequencing Technology Corporation to Offer “Linked Long Read” Sequencing Services". 2023-01-11
Element Biosciences, Inc.. (1/11/23). "Press Release: Element Delivers $200 Genome on AVITI Benchtop Sequencing System". San Diego, CA. 2023-01-11
Bayer AG. (1/10/23). "Press Release: NextPoint Therapeutics Announces $80 Million Series B Financing Co-led by Leaps by Bayer and Sanofi Ventures to Advance Novel Immuno-Oncology Programs". Cambridge, MA & Leverkusen. 2023-01-10
BioNTech SE. (1/10/23). "Press Release: BioNTech to Acquire InstaDeep to Strengthen Pioneering Position in the Field of AI-powered Drug Discovery, Design and Development". Mainz & London. 2023-01-10
1 2 3 ... 68 69 70  next pagenext page


Picture [iito] [LSE] Business Portal 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Kentro Design Corporate and Web Design for Start Ups 2x 650x80px

» top